Health

Consultation: proposals for prescription drug transparency

Health Canada has begun a consultation to seek input on five proposals related to pre-market transparency initiatives for human prescription drugs. All comments received by October 28, 2017 will help inform decisions on the best approach to update and improve current transparency initiatives.

 
 

Updated List of Drugs for an Urgent Public Health Need

The Access to Drugs in Exceptional Circumstances regulatory pathway enables access to drugs which have been authorized for sale in certain foreign jurisdictions, but are not available in Canada, to address urgent public health needs. This pathway is intended for public health events that are exceptional in nature and that are occurring (or imminent) and require immediate action.

 
 

Submissions Under Review

This is a list of certain drug submissions currently under review. The Submissions Under Review list includes the medicinal ingredient(s) and therapeutic area.

 
 

Product Monograph Brand Safety Updates – September 2017

Product Monograph Brand Safety Updates for Submissions cleared between 01-09-2017 and 30-09-2017

 
 

Summary Basis of Decision for DEFITELIO

Health Canada Summary Basis of Decision 2017/09/08. Defitelio, defibrotide, 80 mg/mL, solution, Jazz Pharmaceuticals Ireland Limited. Submission Control Number 200808

 
 

Regulatory Decision Summary for TRESIBA (Control number 168124)

Regulatory Decision Summaries (RDSs) explain Health Canada’s decisions for certain health products seeking market authorization.

 
 

Regulatory Decision Summary for RYDAPT (Control number 201101)

Regulatory Decision Summaries (RDSs) explain Health Canada’s decisions for certain health products seeking market authorization.

 
 

Regulatory Decision Summary for HALAVEN (Control number 197739)

Regulatory Decision Summaries (RDSs) explain Health Canada’s decisions for certain health products seeking market authorization.

 
 

Photo Opportunity with Minister Philpott and Senator Petitclerc

The Honourable Jane Philpott, Federal Minister of Health, along with Senator Chantal Petitclerc, will meet with students regarding the proposed amendments to the Tobacco Act.

 
 

Government of Canada Announces Re-evaluation Decision for Pesticides Containing Boric Acid

Today, the Government of Canada published a final pesticide re-evaluation decision for boric acid, a naturally occurring substance that is commonly used in a wide range of pesticide products in Canada to control insects and fungi.

 
 
 
 

Edmonton on Flickr